Retatrutide + Tirzepatide
Two incretin-based peptide drugs that mimic gut hormones to reduce appetite and slow digestion, leading to significant weight loss and improved blood sugar control. Tirzepatide is FDA-approved for type 2 diabetes and obesity; retatrutide remains in clinical trials.
- Sources carrying it
- 7
- Listings indexed
- 7
- Lowest listed
- $95.03
- Median
- $215.00
- Highest listed
- $450.00
across 10mg → 60mg
Sticker prices in US dollars, across every dosage and pack size (10mg → 60mg) — so the spread includes different quantities, not just different sellers. Prices are the sellers' own listed prices, re-checked periodically rather than tracked daily.
Who lists it & for how much
Members only
The 7 sources that list Retatrutide + Tirzepatide, and what each one charges, are behind the membership. Prices above are the range across every source that lists it — the membership is what tells you which source and for how much, with links and contacts.
Already a member? Sign in
Other peptides indexed
- HCGfrom $2.87
- BPC-157from $12.47
- TB-500from $11.43
- HGHfrom $9.37
- Semaglutidefrom $7.31
- Melanotan IIfrom $18.10
- Tirzepatidefrom $20.00
- GHK-Cufrom $13.27
- NAD+from $15.00
- Retatrutidefrom $36.00
- Ipamorelinfrom $11.99
- IGF-1 LR3from $11.70
Sourcery is an information directory. It does not sell anything and does not handle orders — it indexes what sources publish so they can be compared in one place.